82nd Heidelberg Grand Round - Novel cell based immunotherapy strategies

Thursday 11 Dec 2025, 16:00 → 18:00 Europe/Berlin

Kommunikationszentrum (Lecture Hall) (German Cancer Research Center (DKFZ))

 

 

 

 

 

 

The NCT Heidelberg invites you to the 82nd Heidelberg Grand Round - Novel cell based immunotherapy strategies. We look forward to welcoming you to the event.

The event will take place on December 11, 2025, from 4:00 PM to 6:00 PM at the DKFZ Communication Center, Im Neuenheimer Feld 280, 69120 Heidelberg.

Please register by December 10, 2025, at the latest. The event is free of charge. 

For the 82nd Heidelberg Grand Round, continuing education credits for the event have been requested from Landesärztekammer Baden-Württemberg.

The NCT Heidelberg is a joint venture of the German Cancer Research Center (DKFZ), Heidelberg University Hospital (UKHD), Heidelberg Medicine Faculty of the Heidelberg University and the Thoraxklinik Heidelberg.

Event language: English

 

Organizer:

Heidelberg University Hospital (UKHD) for the National Center for Tumor Diseases (NCT)Heidelberg, (please note the privacy policy of the UKHD)

Hosts: 

• Dirk Jäger, Heidelberg University Hospital (UKHD), German Cancer Research Center (DKFZ), National Center for Tumor Diseases (NCT) Heidelberg
• Carsten Müller-Tidow, Heidelberg University Hospital (UKHD), Heidelberg University, National Center for Tumor Diseases (NCT) Heidelberg
• Christian Seitz, Heidelberg University Hospital (UKHD), German Cancer Research Center (DKFZ), Hopp Children's Cancer Center Heidelberg (KiTZ), National Center for Tumor Diseases (NCT) Heidelberg

 

---

 

 

NCT_HGR-82(Poster)_final.pdf

16:00 → 16:01 Welcome and opening remarks

Speakers: Dirk Jäger (Heidelberg University Hospital (UKHD), German Cancer Research Center (DKFZ), National Center for Tumor Diseases (NCT) Heidelberg), Carsten Müller-Tidow (Heidelberg University Hospital (UKHD), Heidelberg University, National Center for Tumor Diseases (NCT) Heidelberg), Christian Seitz (Heidelberg University Hospital (UKHD), German Cancer Research Center (DKFZ), Hopp Children`s Cancer Center Heidelberg (KiTZ), National Center for Tumor Diseases (NCT) Heidelberg)

16:01 → 16:30 The next frontiers in CAR T cell therapy

Speaker: Carsten Müller-Tidow (Heidelberg University Hospital (UKHD), Heidelberg University, National Center for Tumor Diseases (NCT) Heidelberg)

16:30 → 17:00 GD2-CART01 for pediatric solid tumors: breakthroughs, challenges and path forward

Speaker: Francesca del Bufalo (Bambino Gesù Children's Hospital, Italy)

17:00 → 17:30 PRAMEtime - TCR-engineered T cell therapy in pediatric oncology

Speaker: Christian Seitz (Heidelberg University Hospital (UKHD), German Cancer Research Center (DKFZ), Hopp Children`s Cancer Center Heidelberg (KiTZ), National Center for Tumor Diseases (NCT) Heidelberg)

17:30 → 18:00 Personalized adoptive T cell therapy using vaccination site-infiltrating lymphocytes in patients with metastatic cancer

Speaker: Marten Meyer (German Cancer Research Center (DKFZ), Heidelberg University Hospital (UKHD), National Center for Tumor Diseases (NCT) Heidelberg)